In the BioHarmony Drug Report Database
Letrozole
Femara (letrozole) is a small molecule pharmaceutical. Letrozole was first approved as Femara on 1997-07-25. It is used to treat breast neoplasms in the USA. The pharmaceutical is active against aromatase.
Trade Name
|
Femara |
|---|---|
Common Name
|
letrozole |
ChEMBL ID
|
CHEMBL1444 |
Indication
|
breast neoplasms |
Drug Class
|
Aromatase inhibitors (imidazole/triazole derivatives) |
Image (chem structure or protein)